Robert Edward Furlani

Brackett, C. M., Furlani, R. E., Anderson, R. G., Krishnamurthy, A., Melander, R. J., Moskowitz, S. M., … Melander, C. (2016). Second generation modifiers of colistin resistance show enhanced activity and lower inherent toxicity. TETRAHEDRON, 72(25), 3549–3553. https://doi.org/10.1016/j.tet.2015.09.019

Richardson, M. A., Furlani, R. E., Podell, B. K., Ackart, D. F., Haugen, J. D., Melander, R. J., … Basaraba, R. J. (2015). Inhibition and breaking of advanced glycation end-products (AGEs) with bis-2-aminoimidazole derivatives. TETRAHEDRON LETTERS, 56(23), 3406–3409. https://doi.org/10.1016/j.tetlet.2015.01.122

Furlani, R. E., Richardson, M. A., Podell, B. K., Ackart, D. F., Haugen, J. D., Melander, R. J., … Melander, C. (2015). Second generation 2-aminoimidazole based advanced glycation end product inhibitors and breakers. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 25(21), 4820–4823. https://doi.org/10.1016/j.bmcl.2015.06.080

Furlani, R. E., Yeagley, A. A., & Melander, C. (2013). A flexible approach to 1,4-di-substituted 2-aminoimidazoles that inhibit and disperse biofilms and potentiate the effects of beta-lactams against multi-drug resistant bacteria. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 62, 59–70. https://doi.org/10.1016/j.ejmech.2012.12.005